Interpace Biosciences (OTCMKTS:IDXG) Stock Crosses Above 200-Day Moving Average – Here’s What Happened

Interpace Biosciences, Inc. (OTCMKTS:IDXG) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.41 and traded as high as $2.10. Interpace Biosciences shares last traded at $2.0460, with a volume of 4,515 shares trading hands.

Interpace Biosciences Stock Performance

The stock has a market cap of $9.06 million, a PE ratio of -102.30 and a beta of 0.97. The company’s 50-day moving average price is $1.85 and its 200 day moving average price is $1.41.

About Interpace Biosciences

Interpace Biosciences, Inc provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer.